ICD-10-CM Billable Code

D03.11

Melanoma in situ of right eyelid, including canthus

Clinical Classification Guidelines

Medical Intelligence & Overview

Melanoma in situ of the right eyelid, classified under ICD-10 code D03.11, is a form of skin cancer that is confined to the outermost layer of the skin. It occurs specifically on the right eyelid and can involve the canthus, which is the corner where the eyelids meet. This earliest stage of melanoma is characterized by malignant melanocytes that have not yet invaded deeper layers of the skin or spread to other parts of the body. Recognizing and treating melanoma in situ early is crucial to prevent progression to invasive melanoma, which poses a greater health risk.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning devices. Presence of numerous moles or atypical moles that may increase susceptibility. Fair skin that offers less natural protection from UV rays. History of skin cancer or significant sunburns during childhood or adolescence. Genetic factors and familial predisposition to skin cancers.

Key Symptoms: A new or changing pigmented lesion on the right eyelid or canthus area. Presence of a flat, irregularly shaped, or poorly defined dark spot. Lesion with uneven borders and multiple shades of brown, black, or other colors. Sometimes the lesion may be asymptomatic, but it can also cause irritation or itchiness. Sensation of a persistent sore or lesion that does not heal.

Diagnostic & Treatment

Diagnosis Path: The diagnostic process for melanoma in situ involves a thorough physical examination focusing on the skin lesion. Dermatologists may utilize dermoscopy, a technique that provides a magnified view of skin structures, for better assessment. To confirm the diagnosis, a biopsy of the lesion is performed, typically excisional (removal of the entire lesion) or punch biopsy, followed by microscopic examination to identify malignant melanocytes confined to the epidermis. Further imaging studies are rarely necessary at this stage but may be performed if there's suspicion of spread.

Treatment Protocols: Treatment aims to remove the melanoma in situ completely and prevent progression. Key options include: - Surgical excision: The primary method involves removing the affected tissue with a margin of healthy skin to ensure complete removal. - Mohs micrographic surgery: A precise technique suitable for facial areas, allowing tissue conservation while ensuring complete removal. - Topical therapies: In some cases, topical agents like imiquimod may be used, especially if surgery is contraindicated. - Regular follow-up: Monitoring for any new lesions or recurrence is vital, especially given the sun-exposed location. Early intervention generally results in an excellent prognosis, emphasizing the importance of prompt diagnosis and treatment.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D03.11 a billable ICD-10 code?
Yes, D03.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D03.11?
Clinical documentation must specify the nature of Melanoma in situ of right eyelid, including canthus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference